ZA977308B - Use of complex lipids as stabilizing-additives to pharmaceutical preparations of digestive enzyme mixtures. - Google Patents
Use of complex lipids as stabilizing-additives to pharmaceutical preparations of digestive enzyme mixtures.Info
- Publication number
- ZA977308B ZA977308B ZA9707308A ZA977308A ZA977308B ZA 977308 B ZA977308 B ZA 977308B ZA 9707308 A ZA9707308 A ZA 9707308A ZA 977308 A ZA977308 A ZA 977308A ZA 977308 B ZA977308 B ZA 977308B
- Authority
- ZA
- South Africa
- Prior art keywords
- stabilizing
- additives
- pharmaceutical preparations
- digestive enzyme
- enzyme mixtures
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19634752 | 1996-08-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA977308B true ZA977308B (en) | 1998-02-19 |
Family
ID=7803915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9707308A ZA977308B (en) | 1996-08-28 | 1997-08-14 | Use of complex lipids as stabilizing-additives to pharmaceutical preparations of digestive enzyme mixtures. |
Country Status (1)
| Country | Link |
|---|---|
| ZA (1) | ZA977308B (en) |
-
1997
- 1997-08-14 ZA ZA9707308A patent/ZA977308B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3530997A (en) | Use of complex lipids as stabilising additives to pharmaceutical preparations of digestive enzyme mixtures | |
| PL336889A1 (en) | Preparations of activated protein c | |
| HUP9903613A3 (en) | Improvement in the taste of active pharmaceutical ingredients | |
| HK1015697A1 (en) | Stable freeze-dried pharmaceutical formulation | |
| EP1006998A4 (en) | Topical drug preparations | |
| IL139235A0 (en) | Pharmaceutical preparations | |
| ZA965866B (en) | 6-Dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients | |
| ZA9610650B (en) | 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients | |
| ZA986437B (en) | Derivatives of acyl-piperazinyl-pyrimidines their preparation and application as medicaments | |
| NZ237198A (en) | Zymogen form of protein c, dna, vector and use as a pharmaceutical | |
| PL342362A1 (en) | Water-containing preparations of parasticides applicable onto skin | |
| IL126247A0 (en) | Novel imidazolidine derivatives their preparation their use and pharmaceutical preparations comprising them | |
| HUP9903353A3 (en) | 7alpha-(methyl-amino-pentyl)-estratrienes, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl) -estratrienes and use thereof for production of drugs | |
| CZ63895A3 (en) | 5-vinyl-quinolone-carboxylic, 5-vinyl-naphthyridon-carboxylic, +5-ethinyl-quinolone-carboxylic and 5-ethinyl-naphthyridon-carboxylic acids, process of their preparation, medicaments in which said compounds are comprised and their use | |
| HK1029928A1 (en) | Pharmaceutical compositions of peptides having lowsolubility in physiological medium. | |
| AU9374298A (en) | Preparation and use of biofilm-degrading, multiple-specificit y, hydrolytic enzyme mixtures | |
| AU9395998A (en) | Compositions and methods for the treatment of immune related diseases | |
| DK0925273T3 (en) | Pharmaceutical preparations containing 4-oxo-butanoic acids | |
| AU5693296A (en) | Pectic preparations used as medicament carriers | |
| PL328763A1 (en) | Misolastin containing pharmaceutical preparations of prolonged action | |
| GB9726343D0 (en) | The use of excipients to accelerate freeze-drying | |
| ZA977308B (en) | Use of complex lipids as stabilizing-additives to pharmaceutical preparations of digestive enzyme mixtures. | |
| AU7600598A (en) | Human metaxin protein | |
| AU5263596A (en) | Pharmaceutical formulations of (rhizophora mangle l) | |
| AU2801299A (en) | Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs |